S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSE:USPH

U.S. Physical Therapy (USPH) Stock Price, News & Analysis

$112.86
+1.89 (+1.70%)
(As of 03/28/2024 ET)
Today's Range
$110.94
$113.21
50-Day Range
$92.27
$110.90
52-Week Range
$78.08
$124.11
Volume
65,902 shs
Average Volume
67,669 shs
Market Capitalization
$1.70 billion
P/E Ratio
83.60
Dividend Yield
1.56%
Price Target
$125.67

U.S. Physical Therapy MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
11.3% Upside
$125.67 Price Target
Short Interest
Healthy
4.95% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$1.14 M Sold Last Quarter
Proj. Earnings Growth
10.47%
From $2.77 to $3.06 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.33 out of 5 stars

Medical Sector

480th out of 938 stocks

Health Services Industry

4th out of 10 stocks

USPH stock logo

About U.S. Physical Therapy Stock (NYSE:USPH)

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

USPH Stock Price History

USPH Stock News Headlines

[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
USPH Apr 2024 155.000 call
Q4 2023 US Physical Therapy Inc Earnings Call
U.S. Physical Therapy 2023 Earnings Preview
Best Online Respiratory Therapy Programs Of 2024
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Ex-Dividend for 4/5 Dividend
3/11/2024
Today
3/28/2024
Dividend Payable
4/05/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
Health Care Facilities
CUSIP
90337L10
Employees
6,720
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$125.67
High Stock Price Target
$138.00
Low Stock Price Target
$117.00
Potential Upside/Downside
+11.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$28.24 million
Pretax Margin
8.16%

Debt

Sales & Book Value

Annual Sales
$604.80 million
Cash Flow
$4.80 per share
Book Value
$31.85 per share

Miscellaneous

Free Float
14,797,000
Market Cap
$1.70 billion
Optionable
Optionable
Beta
1.38
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives


USPH Stock Analysis - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price target for 2024?

4 Wall Street analysts have issued 1-year target prices for U.S. Physical Therapy's shares. Their USPH share price targets range from $117.00 to $138.00. On average, they expect the company's share price to reach $125.67 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2024?

U.S. Physical Therapy's stock was trading at $93.14 at the beginning of 2024. Since then, USPH shares have increased by 21.2% and is now trading at $112.86.
View the best growth stocks for 2024 here
.

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our USPH earnings forecast
.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings results on Wednesday, February, 28th. The company reported $0.59 EPS for the quarter, topping analysts' consensus estimates of $0.57 by $0.02. The company had revenue of $154.80 million for the quarter, compared to analyst estimates of $150.24 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 8.52% and a net margin of 4.67%. U.S. Physical Therapy's revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $0.58 EPS.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Tuesday, February 27th. Investors of record on Tuesday, March 12th will be paid a dividend of $0.44 per share on Friday, April 5th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.56%. The ex-dividend date is Monday, March 11th. This is a positive change from the stock's previous quarterly dividend of $0.43.
Read our dividend analysis for USPH
.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.61%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 130.37%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 57.52% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What ETFs hold U.S. Physical Therapy's stock?
What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.09%), Vanguard Group Inc. (7.05%), Copeland Capital Management LLC (4.98%), Boston Trust Walden Corp (3.65%), Southernsun Asset Management LLC (3.20%) and Schroder Investment Management Group (2.85%). Insiders that own company stock include Anne Motsenbocker, Carey P Hendrickson, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Mark J Brookner and Richard Binstein.
View institutional ownership trends
.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:USPH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners